The Biopharma Dilemma: Myths, Facts, and Solutions

  • December 20, 2016
  • 3:00 PM – 4:00 PM ET
  • Online

Health care innovations both enhance and challenge the US health care system.

This webinar will educate stakeholders on key considerations when evaluating new health care innovations for patients.

Webinar participants will learn:

  • Effects of competition and consolidation on health care innovation
  • Factors that contribute to drug costs
  • Potential opportunities for controlling costs while providing high quality care

Who should attend:

  • Payers
  • Formulary decision-makers
  • Health care community


Amitabh ChandraAmitabh Chandra, Chief Scientific Officer, Precision Health Economics
Dr. Amitabh Chandra is Precision Health Economics’ Chief Scientific Officer. In addition, Dr. Chandra serves as a Professor of Public Policy and Director of Health Policy Research at the Harvard Kennedy School of Government. He is a member of the Congressional Budget Office’s (CBO) Panel of Health Advisors, and is a Research Associate at the IZA Institute in Bonn, Germany and at the National
Bureau of Economic Research (NBER). His research has been published in the American Economic Review, the Journal of Political Economy, the New England Journal of Medicine, the Journal of the American Medical Association, and Health Affairs. He is an editor of the Review of Economics and Statistics, a former editor of the Journal of Human Resources, and serves on the editorial boards of Economics Letters and the American Economic Journal.

Dr. Chandra has testified to the United States Senate and the United States Commission on Civil Rights. His research has been featured in the New York Times, the Washington Post, CNN, Newsweek, and on National Public Radio. He has been a consultant to the RAND Corporation, Microsoft Research, the Institute of Medicine and the Blue Cross Blue Shield Foundation of Massachusetts. In 2011 he served as Massachusetts’ Special Commissioner on Provider Price Reform.

Dr. Chandra is an elected member of the Institute of Medicine, the first-prize recipient of the Upjohn Institute’s Dissertation Award, the Kenneth Arrow Award for best paper in health economics, and the Eugene Garfield Award for the impact of medical research. In 2012, he was awarded American Society of Health Economists (ASHE) medal. The ASHE Medal is awarded biennially to the economist age 40 or under who has made the most significant contributions to the field of health economics.